Some cold hard truthafter a few years, it is becoming unreasonable to go against the following assumptions:
-the interest of insiders and of outsiders regarding the stock valaution is not favorable (no insider buyer in years, or of newcomers and no major interest of outsiders)
-the reliability of the base business and its value (we will see within days, but the market is expecting a result that would have little impact to valuation)
-the potential and value of PGX, today, CZO ultimately still has little to show with no clinical evidence or commercial agreements and could still take 1, 2 or more years before it returns real value (based on the past experience, it is not unthinkable that CZO would build the plant out and still not have a deal)
due to the above, i see very difficult the way up of the share price today. unless a game changer happens overnight, which does not seem the case as all initiatives seem far away or eventually disapear/get shelfed.
the only solution i see, is from within the company... insider purchases, company stock buy back, change of CEO/change of strategy in order to demsotrate a new potential value to a stagnant company.